In the current study, although the type 2 diabetes and AD pathways work together in inducing the atrophy of subcortical structures and promoting cognitive decline, we did not find associations between type 2 diabetes and brain amyloid or CSF p-tau levels (Figure 4E). Here, MAPT is linked to type 2 diabetes mellitus.